Management attributes the 2025 performance surge to a successful three-year strategic transformation that addressed labor market challenges by aligning clinical capacity with preferred payers.

The 'Preferred Payer' strategy is the primary driver of margin stabilization, as it directs staffing toward partners willing to engage in enhanced reimbursement and value-based agreements.

Revenue growth in Private Duty Services (PDS) was fueled by a 10.2% increase in revenue per hour, reflecting the shift toward higher-reimbursement preferred payer volumes.

Home Health outperformance was driven by a disciplined focus on an episodic-only model, which now accounts for 78% of the segment's mix and supports double-digit organic growth.

Medical Solutions results were temporarily bolstered by a $2.5 million to $3 million reserve release from improved cash collections, though the segment is undergoing a similar preferred payer pivot.

Management emphasizes that the industry faces a capacity constraint rather than a demand problem, with government and MCO partners actively seeking home-based solutions to reduce total care costs.

The 2026 guidance assumes a transition to 'normalized' growth, with PDS rate enhancements expected to moderate to high single-digits (6-8 states) compared to 10 states in 2025.

Management targets expanding preferred payer agreements to 38 in PDS, 50 in Home Health, and 25 in Medical Solutions by the end of 2026.

The Medical Solutions segment is expected to maintain mid-single-digit growth in the first half of 2026 before returning to double-digit growth following the completion of efficiency initiatives.

Strategic priorities for 2026 include implementing AI and automation for operational productivity and pursuing M&A to densify current markets and enter new geographies like the 'Heartland' states.

Financial guidance for 2026 excludes the impact of the Family First acquisition, which is expected to close in late Q2 pending regulatory approvals.

The acquisition of Family First Home Care for $175.5 million (7.5x post-synergy EBITDA) is intended to densify the Florida market and expand geographic reach to every county in the state.

The 53rd week in the 2025 fiscal calendar provided a non-recurring boost to revenue and EBITDA that will not repeat in the 2026 comparable periods.

California remains a strategic outlier with no rate increases included in the state's 2026-2027 budget; management has modeled no material improvement for this market in their guidance.

Net leverage reached approximately 4x at year-end 2025, with management intending to maintain or slightly reduce this level while funding acquisitions through cash on hand and existing facilities.

Our analysts just identified a stock with the potential to be the next Nvidia. Tell us how you invest and we'll show you why it's our #1 pick. Tap here.

Management expects a minimal short-term impact on leverage, with the goal to remain flat or slightly deleverage by year-end 2026 through strong free cash flow.

The deal is valued at 7.5x post-synergy EBITDA and is described as a 'middle of the fairway' transaction similar to the previous Thrive acquisition.

Management confirmed a long-term strategy to keep episodic mix above 75%, noting that payers have adapted to Aveanna's refusal to accept low-dollar fee-for-service contracts.

High clinical ratings (4.3 stars) are cited as the primary leverage used to maintain these preferred reimbursement structures.

Margins are expected to return to the 43% to 45% range in Q1 2026 following the one-time reserve release in Q4 2025.

Double-digit organic volume growth is expected to resume in the second half of 2026 once modernization and payer alignment efforts are finalized.

Current growth is focused on densifying existing markets, but management identified Ohio, West Virginia, Kentucky, and Tennessee as primary targets for future M&A.

The goal is to fill in the 'Heartland' gap where the company currently lacks a Medicaid service presence.

One stock. Nvidia-level potential. 30M+ investors trust Moby to find it first. Get the pick. Tap here.